potassium 1-(4-methoxybenzyl)tetrazole-5-carboxylate | 70977-77-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: potassium 1-(4-methoxybenzyl)tetrazole-5-carboxylate
• 英文别名: potassium 1-(4-methoxyphenylmethyl)-1H-tetrazole-5-carboxylate；Potassium 1-(4-methoxybenzyl)-1H-tetrazole-5-carboxylate；potassium;1-[(4-methoxyphenyl)methyl]tetrazole-5-carboxylate
• CAS: 70977-77-4
• 化学式: C₁₀H₉N₄O₃*K
• 分子量: 272.305
• InChiKey: TUGMKLVPTRKXOI-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -3.9
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  93
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  potassium 1-(4-methoxybenzyl)tetrazole-5-carboxylate 在 吡啶 、 氯化亚砜 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 2.0h， 生成 1-(4-methoxy-benzyl)-1H-tetrazole-5-carboxylic acid 3-acetyl-5-ethyl-2-hydroxy-anilide
  参考文献：
  名称：

  Synthesis and quantitative structure-activity relationships of antiallergic 2-hydroxy-N-(1H-tetrazol-5-yl)benzamides and N-(2-hydroxyphenyl)-1H-tetrazole-5-carboxamides

  摘要：

  The synthesis and antiallergic activity of a series of 2-hydroxy-N-1H-tetrazol-5-ylbenzamides and isomeric N-(2-hydroxyphenyl)-1H-tetrazole-5-carboxamides is described. A relationship between structure and intravenous antiallergic activity in the rat passive cutaneous anaphylaxis (PCA) test has been established using a Hansch/Free-Wilson model and used to direct studies toward potent derivatives. The contribution of physicochemical properties to activity is discussed. One member of this series, N-(3-acetyl-5-fluoro-2-hydroxyphenyl)-1H-tetrazole-5-carboxamide (3f), which was selected for further evaluation, has an ID50 value of 0.16 mg/kg po and is 130 times more potent than disodium cromoglycate (DSCG) on intravenous administration.

  DOI：

  10.1021/jm00154a019
• 作为产物：
  描述：

  ethyl N-(4-methoxybenzyl)oxamate 在 吡啶 、 氢氧化钾 、 迭氮酸 、 五氯化磷 作用下， 以 乙醇 、 二氯甲烷 、 苯 为溶剂， 反应 7.0h， 生成 potassium 1-(4-methoxybenzyl)tetrazole-5-carboxylate
  参考文献：
  名称：

  5-四唑甲酰胺及其盐：新型口服活性抗过敏药。

  摘要：

  DOI：

  10.1021/jm00138a021
• 作为试剂：
  描述：

  potassium 1-(4-methoxybenzyl)tetrazole-5-carboxylate 、 3-[3-(4-acetyl-3-hydroxy-2-n-propylphenoxy)-propoxy]-4-chloro-6-methylaniline 在 potassium 1-(4-methoxybenzyl)tetrazole-5-carboxylate 作用下， 生成 N-3-[3-(4-acetyl-3-hydroxy-2-n-propylphenoxy)-propoxy]-4-chloro-6-methylphenyl-1-(4-methoxybenzyl)-tetrazole-5-carboxamide
  参考文献：
  名称：

  Novel resorcinol ethers and anti-inflammatory and anti-allergic use

  摘要：

  该公式的小说4-酰基邻苯二酚醚化合物，其中R.sub.1代表较低的烷基，R.sub.2代表较低的烷基，较低的烯基或较低的炔基，R.sub.3代表氢，较低的烷氧基，三氟甲基或卤素，alk代表烷基基团，其中R.sub.4，R.sub.5和R.sub.7中的一个基团是--NH--C(.dbd.O)--R.sub.8的基团，除了--NH--C(.dbd.O)--R.sub.8的基团是R.sub.9的基团和除了--NH--C(.dbd.O)--R.sub.8的基团是R.sub.10的基团之外，R.sub.6代表氢，较低的烷基，卤素，三氟甲基，可选地酯化或酰胺化的羧基，氰基或较低的烷酰基，R.sub.8代表可选地酯化或酰胺化的羧基，或5-四氮唑基，R.sub.9代表氢，较低的烷基，较低的烷氧基，卤素或三氟甲基，R.sub.10代表氢，较低的烷基，较低的烷氧基，卤素，三氟甲基，氰基或可选地酯化或酰胺化的羧基，它们的盐具有LTD.sub.4-拮抗和PLA.sub.2-磷脂酶抑制性能。它们可以根据已知方法制造。

  公开号：

  US04863942A1

文献信息

• 2'Hydroxy tetrazole-5-carboxanilides and anti-allergic use thereof
  申请人：May & Baker Limited

  公开号：US04442115A1

  公开（公告）日：1984-04-10

  New tetrazole derivatives of the general formula: ##STR1## [wherein R.sup.1 represents a halogen atom, a straight- or branched-chain alkyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl or alkylsulphamoyl group, each such group containing from 1 to 6 carbon atoms, a dialkylsulphamoyl, dialkylamino, or dialkylcarbamoyl group (wherein the two alkyl groups may be the same or different and each contains from 1 to 4 carbon atoms), a straight- or branched-chain alkanoyl, alkoxycarbonyl, alkoxycarbonylamino, alkylcarbamoyl or alkanoylamino group containing from 2 to 6 carbon atoms, a cycloalkylcarbonyl group containing from 3 to 8 carbon atoms in the cycloalkyl moiety, or a hydroxy, formyl, nitro, trifluoromethyl, trifluoroacetyl, aryl, benzyloxycarbonylamino, amino, sulphamoyl, cyano, tetrazol-5-yl, carboxy, carbamoyl, benzyloxy, aralkanoyl or aroyl group, or a group of the formula: --CR.sup.2 .dbd.NOR.sup.3 II (wherein R.sup.2 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 5 carbon atoms, an aryl, aralkyl or trifluoromethyl group, or a cycloalkyl group containing from 3 to 8 carbon atoms, and R.sup.3 represents a hydrogen atom, or a straight- or branched-chain alkyl group containing from 1 to 6 carbon atoms optionally substituted by a phenyl group, or represents an aryl group optionally substituted by one or more substituents selected from halogen atoms and straight- or branched-chain alkyl and alkoxy groups containing from 1 to 6 carbon atoms and hydroxy, trifluoromethyl and nitro groups), and m represents zero or an integer 1, 2 or 3, the substituents R.sup.1 being the same or different when m represents 2 or 3] possess pharmacological properties, in particular properties of value in the treatment of allergic conditions.

  新的四唑衍生物的一般化学式为：##STR1##[其中R.sup.1代表卤素原子，直链或支链烷基，烷氧基，烷硫基，烷基亚硫酰基，烷基磺酰基或烷基磺胺基，每个这样的基团含有1至6个碳原子，双烷基磺酰胺基，双烷基氨基或双烷基氨基甲酰基（其中两个烷基可能相同或不同，每个含有1至4个碳原子），直链或支链脂肪酰基，烷氧基羰基，烷氧基羰基氨基，烷基甲酰胺基或脂肪酰胺基含有2至6个碳原子，环烷基羰基含有3至8个碳原子的环烷基基团，或羟基，甲酰基，硝基，三氟甲基，三氟乙酰基，芳基，苄氧羰胺基，氨基，磺酰胺基，氰基，四唑-5-基，羧基，氨基甲酰基，苄氧基，芳基酰基或芳酰基，或式子：--CR.sup.2.dbd.NOR.sup.3 II（其中R.sup.2代表氢原子或含有1至5个碳原子的直链或支链烷基，芳基，芳基烷基或三氟甲基基团，或含有3至8个碳原子的环烷基基团，R.sup.3代表氢原子，或含有1至6个碳原子的直链或支链烷基基团，可选择地由苯基取代，或表示由一个或多个取代基选择的卤素原子和直链或支链烷基和烷氧基基团，含有1至6个碳原子和氢氧基，三氟甲基和硝基基团），m表示零或整数1、2或3，当m表示2或3时，取代基R.sup.1相同时或不同时]具有药理学性质，特别是在治疗过敏症状方面具有价值的性质。
• N-[4-[.omega.-(4-acyl-3-hydroxyphenoxy)alkoxy]-p
  申请人：Lilly Industries Limited

  公开号：US04675333A1

  公开（公告）日：1987-06-23

  There are described compounds of the formula ##STR1## in which R.sup.1 is hydrogen or C.sub.1-6 alkyl, R.sup.2 is hydrogen, C.sub.1-6 alkyl or C.sub.3-6 alkenyl, R.sup.3 is hydrogen or C.sub.1-6 alkyl, R.sup.4 is hydrogen or an N-protecting group, n is 2, 3, 4 or 5, and X is oxygen, sulphur or --CH.sub.2 --, provided that when X is --CH.sub.2 -- n is 0; and salts thereof. The compounds in which R.sup.4 is hydrogen have pharmaceutical activity.

  该公式描述了化合物，其中R.sup.1为氢或C.sub.1-6烷基，R.sup.2为氢，C.sub.1-6烷基或C.sub.3-6烯基，R.sup.3为氢或C.sub.1-6烷基，R.sup.4为氢或N-保护基，n为2、3、4或5，X为氧、硫或--CH.sub.2 --，但当X为--CH.sub.2 --时，n为0；及其盐。其中R.sup.4为氢的化合物具有药用活性。
• N-(substituted phenyl) tetrazol-5-yl carboxamides and anti-allergic use
  申请人：Ciba-Geigy Corporation

  公开号：US04808604A1

  公开（公告）日：1989-02-28

  Novel 4-acylresorcinol ethers of the formula ##STR1## in which R.sub.1 is lower alkyl, alk is a hydroxyalkylene radical which can be interrupted by oxygen and R.sub.2 is 5-tetrazolyl, it being possible for the ring A to be additionally substituted by a lower alkyl, lower alkenyl, lower alkynyl, lower alkoxy and/or halogen and for the ring B to be additionally substituted by lower alkyl, lower alkanoyl, lower alkoxy, lower alkoxycarbonyl, carboxyl, cyano, carbamyl, halogen and/or trifluoromethyl, and salts thereof have antiallergic properties and can be used as active compounds for medicaments. They are prepared by methods known as per se.

  该专利描述了一种化合物，分子式为##STR1##，其中R.sub.1为较低的烷基，alk为一个可以被氧中断的羟基烷基基团，R.sub.2为5-四唑基，环A可以额外被较低的烷基、较低的烯基、较低的炔基、较低的烷氧基和/或卤素取代，环B可以额外被较低的烷基、较低的酰基、较低的烷氧基、较低的烷氧羰基、羧基、氰基、氨基、卤素和/或三氟甲基取代，以及其盐具有抗过敏性能，并可用作药物的活性化合物。它们可通过已知的方法制备。
• Novel fluorinated resorcinol ethers
  申请人：Ciba-Geigy Corporation

  公开号：US04670604A1

  公开（公告）日：1987-06-02

  4-Acylresorcinol ethers of the formula ##STR1## in which R.sub.1 is lower alkyl, R.sub.2 is fluorinated lower alkyl, R.sub.3 is hydrogen, lower alkoxy, trifluoromethyl or halogen, alk is an alkylene or hydroxyalkylene radical which is uninterrupted or interrupted by oxygen, one of the radicals R.sub.4, R.sub.5 and R.sub.7 is a group of the formula --NH--C(.dbd.O)--R.sub.8, a radical R.sub.4 or R.sub.5 which differs from this is a radical R.sub.9 and a radical R.sub.7 which differs from this is a radical R.sub.10, R.sub.6 is hydrogen, lower alkyl, trifluoromethyl, halogen, carboxyl which is free, esterified or amidated, cyano or lower alkanoyl, R.sub.8 is carboxyl which is free, esterified or amidated or 5-tetrazolyl, R.sub.9 is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl and R.sub.10 is hydrogen, lower alkyl, lower alkoxy, halogen, trifluoromethyl, cyano or carboxyl which is free, esterified or amidated, and their salts have antiallergic and antiinflammatory properties. They are prepared, for example, by reacting compounds of the formulae ##STR2## in which one of the radicals X.sub.5 and X.sub.6 is hydroxyl which is free or in salt form and the other is an alkoxy radical substituted by reactive esterified hydroxyl or epoxy. The invention also relates to intermediates of the formula ##STR3## in which R.sub.2 is fluorinated lower alkyl, R.sub.3 is hydrogen, lower alkoxy, trifluoromethyl or halogen and R.sub.11 is hydrogen or a group of the formula R.sub.1 --O(.dbd.O)--, in which R.sub.1 is lower alkyl, and their salts.

  公式为##STR1##的4-酰基邻苯二酚醚中，其中R.sub.1为较低的烷基，R.sub.2为氟代较低的烷基，R.sub.3为氢、较低的烷氧基、三氟甲基或卤素，alk为未受氧或被氧中断的烷基或羟基烷基基团，R.sub.4、R.sub.5和R.sub.7中的一个是--NH--C(.dbd.O)--R.sub.8的基团，与此不同的基团R.sub.4或R.sub.5是基团R.sub.9，与此不同的基团R.sub.7是基团R.sub.10，R.sub.6为氢、较低的烷基、三氟甲基、卤素、游离的、酯化的或酰胺化的羧基、氰基或较低的烷酰基，R.sub.8为游离的、酯化的或酰胺化的羧基或5-四唑基，R.sub.9为氢、较低的烷基、较低的烷氧基、卤素或三氟甲基，R.sub.10为氢、较低的烷基、较低的烷氧基、卤素、三氟甲基、氰基或游离的、酯化的或酰胺化的羧基，以及它们的盐具有抗过敏和抗炎性能。例如，通过反应下列公式的化合物制备它们：##STR2##其中X.sub.5和X.sub.6中的一个是游离的或盐形式的羟基，另一个是被反应性酯化羟基或环氧基取代的烷氧基基团。该发明还涉及公式##STR3##中的中间体，其中R.sub.2为氟代较低的烷基，R.sub.3为氢、较低的烷氧基、三氟甲基或卤素，R.sub.11为氢或R.sub.1--O(.dbd.O)--的基团，其中R.sub.1为较低的烷基，以及它们的盐。
• Oxaloamino substituted fluorinated resorcinol ethers and anti-allergic
  申请人：Ciba-Geigy Corporation

  公开号：US04820726A1

  公开（公告）日：1989-04-11

  4-Acylresorcinol esthers of the formula ##STR1## in which R.sub.1 is lower alkyl, R.sub.2 is fluorinated lower alkyl, R.sub.3 is hydrogen, lower alkoxy, trifluoromethyl or halogen, alk is an alkylene or hydroxyalkylene radical which is uninterrupted or interrupted by oxygen, one of the radicals R.sub.4, R.sub.5 and R.sub.7 is a group of the formula --NH--C(.dbd.O)--R.sub.8, a radical R.sub.4 or R.sub.5 which differs from this is a radical R.sub.9 and a radical R.sub.7 which differs from this is a radical R.sub.10, R.sub.6 is hydrogen, lower alkyl, trifluoromethyl, halogen, carboxyl which is free, esterified or amidated, cyano or lower alkanoyl, R.sub.8 is carboxyl which is free, esterified or amidated or 5-tetrazolyl, R.sub.9 is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl and R.sub.10 is hydrogen, lower alkyl, lower alkoxy, halogen, trifluoromethyl, cyano or carboxyl which is free, esterified or amidated, and their salts have antiallergic and antiinflammatory properties. They are prepared, for example, by reacting compounds of the formulae ##STR2## in which one of the radicals X.sub.5 and X.sub.6 is hydroxyl which is free or in salt form and the other is an alkoxy radical substituted by reactive esterified hydroxy or epoxy. The invention also relates to intermediates of the formula ##STR3## in which R.sub.2 is fluorinated lower alkyl, R.sub.3 is hydrogen, lower alkoxy, trifluoromethyl or halogen and R.sub.11 is hydrogen or a group of the formula R.sub.1 --C(--O)--, in which R.sub.1 is lower alkyl, and their salts.

  公式为##STR1##的4-酰基邻苯二酚酯，其中R.sub.1为较低的烷基，R.sub.2为氟化的较低的烷基，R.sub.3为氢、较低的烷氧基、三氟甲基或卤素，alk为未被氧中断或中断的烷基或羟基烷基基团，R.sub.4、R.sub.5和R.sub.7中的一个是--NH--C(.dbd.O)--R.sub.8的基团，与此不同的基团R.sub.4或R.sub.5是基团R.sub.9，与此不同的基团R.sub.7是基团R.sub.10，R.sub.6为氢、较低的烷基、三氟甲基、卤素、游离的、酯化的或酰化的羧基、氰基或较低的烷酰基，R.sub.8为游离的、酯化的或酰化的羧基或5-四唑基，R.sub.9为氢、较低的烷基、较低的烷氧基、卤素或三氟甲基，R.sub.10为氢、较低的烷基、较低的烷氧基、卤素、三氟甲基、氰基或游离的、酯化的或酰化的羧基，它们的盐具有抗过敏和抗炎性能。例如，通过反应公式为##STR2##的化合物制备。其中，X.sub.5和X.sub.6中的一个是游离的或盐形式的羟基，另一个是被反应酯化的羟基或环氧基取代的烷氧基基团。本发明还涉及公式为##STR3##的中间体，其中R.sub.2为氟化的较低的烷基，R.sub.3为氢、较低的烷氧基、三氟甲基或卤素，R.sub.11为氢或R.sub.1--C(--O)--的基团，其中R.sub.1为较低的烷基，以及它们的盐。